HIV infection among pregnant women in Bobo-Dioulasso, Burkina Faso: Comparison of voluntary and blinded seroprevalence estimates

International Journal of STD and AIDS

Volumn 10, Issue 11, 1999, Pages 738-740

  Meda, Nicolas ^a   Zoundi Guigui, Marie Therese ^b   Van de Perre, Philippe ^a   Alary, Michel ^e   Ouangré, Amadou ^a   Cartoux, Michel ^a   Mandelbrot, Laurent ^c   Viens, Pierre ^b   Dabis, François ^d  

^a CENTRE MURAZ   (Burkina Faso)

^b UNIVERSITÉ LAVAL   (Canada)

^c Hôpital Cochin ^*  (France)

^d INSERM   (France)

^e Centre MURAZ/OCCGE ^*

Author keywords

Africa; HIV; Methods; Pregnant women; Surveillance

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; BURKINA FASO; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; NORMAL HUMAN; PREGNANCY; PRIORITY JOURNAL; SCREENING; SEROPREVALENCE; SINGLE BLIND PROCEDURE; VERTICAL TRANSMISSION;

AFRICA; AFRICA SOUTH OF THE SAHARA; BURKINA FASO; COMPARATIVE STUDIES; DEMOGRAPHIC FACTORS; DEVELOPING COUNTRIES; DISEASES; FRENCH SPEAKING AFRICA; HIV INFECTIONS--WOMEN; MEASUREMENT; POPULATION; POPULATION CHARACTERISTICS; PREGNANT WOMEN; PREVALENCE; RESEARCH METHODOLOGY; RESEARCH REPORT; STUDIES; VIRAL DISEASES; WESTERN AFRICA; WOMEN;

ADULT; BURKINA FASO; DOUBLE-BLIND METHOD; FEMALE; HIV SEROPREVALENCE; HUMANS; MASS SCREENING; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; SENTINEL SURVEILLANCE; SINGLE-BLIND METHOD;

EID: 0032738742     PISSN: 09564624     EISSN: None     Source Type: Journal    
DOI: 10.1258/0956462991913277     Document Type: Article

References (11)

1. 1 Chin J. Public health surveillance of AIDS and HIV infections. Bull WHO 1990;68:529-36
2. 2 Cartoux M, Msellati P, Rouamba O, et al. Acceptability of interventions to reduce mother-to-child transmission of HIV-1 in West Africa. J Acquir Immune Defic Syndr Hum Retrovirol 1996;12:290-2
3. 3 Schwarcz SK, Bolan GA, Kellogg TA, Kohn R, Lemp GF. Comparison of voluntary and blinded human immunodeficiency virus type 1 (HIV-1) seroprevalence surveys in a high prevalence sexually transmitted disease clinic population. Am J Epidemiol 1993;137:600-8
4. 4 Chaisson MA, Stoneburner RL, Lifson AR, et al. Risk factors for human immunodeficiency virus type 1 (HIV-1) in patients at sexually transmitted disease clinic in New York City. Am J Epidemiol 1990;131:208-20
5. 5 Sangaré L, Meda N, Lankoandé S, et al. HIV infection among pregnant women in Burkina Faso: a nationwide serosurvey. Int J STD AIDS 1997;8:646-51
6. 6 Miotti P, Canner J, Chipangwi J, Liomba G, Saah A, Dallabetta G. Rate of new HIV infection in a cohort of women of childbearing age in Malawi. AIDS Res Human Retrovirol 1994;10(suppl 2):S239-S241
7. 7 Batter V, Matela B, Nsuami M, et al. High HIV-1 incidence in young women masked by stable overall seroprevalence among childbearing women in Kinshasa, Zaïre: estimating incidence from serial seroprevalence data. AIDS 1994;8:811-17
8. 8 Sylla-Koko F, Anglaret X, Traoré-Anaky MF, et al. Séroprévalence de l'infection par le VIH dans les consultations prénatales d'Abidjan, Côte d'Ivoire, 1995. Méd Mal Infect 1997;27:127-8
9. 9 The Working Group on Mother-To-Child Transmission of HIV. Rates of mother-to-child transmission of HIV-1 in Africa, America and Europe: results from 13 perinatal studies. J Acquir Immune Defic Syndr Hum Retrovirol 1995;8:506-10
10. 10 Couturier E, Brossard Y, Larsen C, et al. HIV infection at outcome of pregnancy in the Paris area, France. Lancet 1992;340:707-9
11. 11 Meda N, Msellati P, Wellfens-Ekra C, et al. Réduction de la transmission mère-enfant du VIH dans les pays en développement: stratégies d'intervention disponibles, obstacles à leur mise en oeuvre et perspectives. Cahiers Santé 1997;7:115-25